Cantor Fitzgerald & Robbins Geller Rudman & Dowd LLP
3 shared events · Importance 3 · Last updated Aug 18, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Cantor Fitzgerald: Analyst firm that published a negative note on the FDA briefing documents.
Robbins Geller Rudman & Dowd LLP: Law firm that announced the class action lawsuit.
Jul 27, 2026 · 305 articles
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics stock from Overweight to Neutral following the Culper Research report.
Robbins Geller Rudman & Dowd LLP: Robbins Geller Rudman & Dowd LLP announces the class action lawsuit against ADMA Biologics and seeks lead plaintiff.
Jun 14, 2026 · 294 articles
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald analyst Kristen Kluska published an investor note stating the FDA briefing documents paint an ugly picture and raise concerns about the integrity of data collection, a view cited in the complaint.
Robbins Geller Rudman & Dowd LLP: Plaintiff law firm announcing the Capricor class action and the September 28, 2026 lead plaintiff deadline.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Cantor Fitzgerald and Robbins Geller Rudman & Dowd LLP interact across events, view sentiment trends, and discover connected entities.
Open Dashboard